Scientists test Patient's own supercharged immune cells to fight lung cancer
NCT ID NCT07202611
Summary
This study is testing whether a personalized immune cell therapy is safe for people with advanced non-small cell lung cancer. Doctors take a patient's own immune cells, grow large numbers of them in a lab, and then inject them back into the patient to help fight the cancer. The trial is for patients whose cancer has continued to grow despite trying at least two other standard treatments like chemotherapy or immunotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital Yunlin Branch
RECRUITINGHuwei, YUNLIN, 640, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.